Human serum albumin can regulate amyloid-β peptide fiber growth in the brain interstitium: Implications for Alzheimer disease

Journal of Biological Chemistry

Volumn 287, Issue 33, 2012, Pages 28163-28168

  Stanyon, Helen F ^a   Viles, John H ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOID FIBERS; BLOOD PLASMA; EXTRACELLULAR ACCUMULATIONS; FIBRIL GROWTH; FIBRILLIZATION; HUMAN SERUM ALBUMINS; LAG-TIME; NEURODEGENERATIVE DISORDERS; PEPTIDE FIBERS; PERIPHERAL TISSUE;

BRAIN; CEREBROSPINAL FLUID; GLYCOPROTEINS; PEPTIDES; TISSUE;

NEURODEGENERATIVE DISEASES;

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; HUMAN SERUM ALBUMIN;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; HUMAN; INTERSTITIUM; NERVE FIBER GROWTH; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; BRAIN; BRAIN CHEMISTRY; HUMANS; SERUM ALBUMIN;

EID: 84865007775     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.C112.360800     Document Type: Article

References (32)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer disease: progress and problems on the road to therapeutics. Science 297, 353-356
2. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., and Swindlehurst, C. (1992) Isolation and quantification of soluble Alzheimer β-peptide from biological fluids. Nature 359, 325-327
3. Lame, M. E., Chambers, E. E., and Blatnik, M. (2011) Quantitation of amyloid-β peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry. Anal. Biochem. 419, 133-139
4. Biere, A. L., Ostaszewski, B., Stimson, E. R., Hyman, B. T., Maggio, J. E., and Selkoe, D. J. (1996) Amyloid-β peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271, 32916-32922
5. Kuo, Y. M., Kokjohn, T. A., Kalback, W., Luehrs, D., Galasko, D. R., Chevallier, N., Koo, E. H., Emmerling, M. R., and Roher, A. E. (2000) Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem. Biophys. Res. Commun. 268, 750-756
6. Carter, D. C., and Ho, J. X. (1994) Structure of serum albumin. Adv. Protein Chem. 45, 153-203
7. Stevens, R. W., Elmendorf, D., Gourlay, M., Stroebel, E., and Gaafar, H. A. (1979) Application of fluoroimmunoassay to cerebrospinal fluid immunoglobulin G and albumin. J. Clin. Microbiol. 10, 346-350
8. Rózga, M., Kłoniecki, M., Jabłonowska, A., Dadlez, M., and Bal, W. (2007) The binding constant for amyloid Aβ40 peptide interaction with human serum albumin. Biochem. Biophys. Res. Commun. 364, 714-718
9. Bohrmann, B., Tjernberg, L., Kuner, P., Poli, S., Levet-Trafit, B., Näslund, J., Richards, G., Huber, W., Döbeli, H., and Nordstedt, C. (1999) Endogenous proteins controlling amyloid-β peptide polymerization: possible implications for β-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem. 274, 15990-15995
10. Milojevic, J., Esposito, V., Das, R., and Melacini, G. (2007) Understanding the molecular basis for the inhibition of the Alzheimer Aβ-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. J. Am. Chem. Soc. 129, 4282-4290
11. Milojevic, J., and Melacini, G. (2011) Stoichiometry and affinity of the human serum albumin-Alzheimer Aβ peptide interactions. Biophys. J. 100, 183-192
12. Milojevic, J., Raditsis, A., and Melacini, G. (2009) Human serum albumin inhibits Aβ fibrillization through a "monomer-competitor" mechanism. Biophys. J. 97, 2585-2594
13. Reyes Barcelo, A. A., Gonzalez-Velasquez, F. J., and Moss, M. A. (2009) Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells. J. Biol. Eng. 3, 5-12
14. Uversky, V. N., Li, J., and Fink, A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein: a possible molecular NK between Parkinson disease and heavy metal exposure. J. Biol. Chem. 276, 44284-44296
15. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128-1132
16. Likó, I., Mák, M., Klement, E., Hunyadi-Gulyás, E., Pázmány, T., Medzihradszky, K. F., and Urbányi, Z. (2007) Evidence for an extended interacting surface between β-amyloid and serum amyloid P component. Neurosci. Lett. 412, 51-55
17. Andreetto, E., Yan, L. M., Tatarek-Nossol, M., Velkova, A., Frank, R., and Kapurniotu, A. (2010) Identification of hot regions of the Aβ-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. Angew. Chem. Int. Ed. Engl. 49, 3081-3085
18. Buxbaum, J. N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A. R., and Bartfai, T. (2008) Transthyretin protects Alzheimer mice from the behavioral and biochemical effects of Aβ toxicity. Proc. Natl. Acad. Sci. U.S.A. 105, 2681-2686
19. Coria, F., Castaño, E., Prelli, F., Larrondo-Lillo, M., van Duinen, S., Shelanski, M. L., and Frangione, B. (1988) Isolation and characterization of amyloid P component from Alzheimer disease and other types of cerebral amyloidosis. Lab. Invest. 58, 454-458
20. Curry, S., Mandelkow, H., Brick, P., and Franks, N. (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5, 827-835
21. Patel, S. U., Sadler, P. J., Tucker, A., and Viles, J. H. (1993) Direct detection of albumin in human blood plasma by proton NMR spectroscopy. Complexation of nickel2+. J. Am. Chem. Soc. 115, 9285-9286
22. Sarell, C. J., Wilkinson, S. R., and Viles, J. H. (2010) Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-β from Alzheimer disease. J. Biol. Chem. 285, 41533-41540
23. You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., Engbers, J. D., Lipton, S. A., Stys, P. K., and Zamponi, G. W. (2012) Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 109, 1737-1742
24. Viles, J. H. (2012) Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and Prion disease. Coord. Chem. Rev., in press
25. Perrone, L., Mothes, E., Vignes, M., Mockel, A., Figueroa, C., Miquel, M. C., Maddelein, M. L., and Faller, P. (2010) Copper transfer from Cu-Aβ to human serum albumin inhibits aggregation, radical production and reduces Aβ toxicity. ChemBioChem 11, 110-118
26. Licastro, F., Morini, M. C., Davis, L. J., Biagi, R., Prete, L., and Savorani, G. (1993) Studies of blood-brain-barrier permeability and of intrathecal IgG synthesis in patients with Alzheimer's Disease and multi-infarct dementia. Adv. Biosci. 87, 283-284
27. Christenson, R. H., Behlmer, P., Howard, J. F., Jr., Winfield, J. B., and Silverman, L. M. (1983) Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. Clin. Chem. 29, 1028-1030
28. Elovaara, I., Maury, C. P., and Palo, J. (1986) Serum amyloid A protein, albumin, and prealbumin in Alzheimer disease and in demented patients with Down syndrome. Acta Neurol. Scand. 74, 245-250
29. Elovaara, I., Palo, J., Erkinjuntti, T., and Sulkava, R. (1987) Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer disease and multi-infarct dementia. Eur. Neurol. 26, 229-234
30. Klonoff-Cohen, H., Barrett-Connor, E. L., and Edelstein, S. L. (1992) Albumin levels as a predictor of mortality in the healthy elderly. J Clin Epidemiol. 45, 207-212
31. Boada, M., Ortiz, P., Anaya, F., Hernández, I., Muñoz, J., Núñez, L., Olazarán, J., Roca, I., Cuberas, G., Tárraga, L., Buendia, M., Pla, R. P., Ferrer, I., and Páez, A. (2009) Amyloid-targeted therapeutics in Alzheimer disease: use of human albumin in plasma exchange as a novel approach for Aβ mobilization. Drug News Perspect. 22, 325-339
32. Mackic, J. B., Weiss, M. H., Miao, W., Kirkman, E., Ghiso, J., Calero, M., Bading, J., Frangione, B., and Zlokovic, B. V. (1998) Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer amyloid-β peptide in aged squirrel monkey with cerebral amyloid angiopathy. J. Neurochem. 70, 210-215